Related references
Note: Only part of the references are listed.Comparison of LC-MS/MS and chemiluminescent immunoassays for immunosuppressive drugs reveals organ dependent variation in blood cyclosporine a concentrations
Anna Becker et al.
CLINICA CHIMICA ACTA (2020)
Recent advances in analytical methods for the therapeutic drug monitoring of immunosuppressive drugs
Yu Zhang et al.
DRUG TESTING AND ANALYSIS (2018)
Assuring the Proper Analytical Performance of Measurement Procedures for Immunosuppressive Drug Concentrations in Clinical Practice: Recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Immunosuppressive Drug Scientific Committee
Christoph Seger et al.
THERAPEUTIC DRUG MONITORING (2016)
Liquid chromatography tandem mass spectrometry for therapeutic drug monitoring of immunosuppressive drugs: Achievements, lessons and open issues
Maria Shipkova et al.
TRAC-TRENDS IN ANALYTICAL CHEMISTRY (2016)
Multicenter Analytical Evaluation of the Automated Electrochemiluminescence Immunoassay for Cyclosporine
Michael Vogeser et al.
THERAPEUTIC DRUG MONITORING (2014)
The Need for Standardization of Tacrolimus Assays
Daniel M. Levine et al.
CLINICAL CHEMISTRY (2011)
Development of an Abbott ARCHITECT cyclosporine immunoassay without metabolite cross-reactivity
Elaine M. Brate et al.
CLINICAL BIOCHEMISTRY (2010)
Multisite Analytical Evaluation of the Abbott ARCHITECT Cyclosporine Assay
Pierre Wallemacq et al.
THERAPEUTIC DRUG MONITORING (2010)
Cyclosporin: revisions in monitoring guidelines and review of current analytical methods
D Andrews et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2002)
Therapeutic drug monitoring of inununosuppressant drugs in clinical practice
BD Kahan et al.
CLINICAL THERAPEUTICS (2002)
Share Paper
